Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Mol Genet Metab. 2013 Jun 25;110(3):275–280. doi: 10.1016/j.ymgme.2013.06.014

Fig. 3.

Fig. 3

Fasting blood glucose and glucose tolerance profiles in 12-week-old wild type and rAAV8-treated G6pc−/− mice. (A) Fasting blood glucose profiles. (B) Blood glucose levels following a 24-hour fast. (C) Glucose tolerance profiles. GPE-high (n = 6), high dose rAAV8-GPE-treated (○); miGPE-high (n = 6), high dose rAAV8-miGPE-treated (●); GPE-low (n = 6), low dose rAAV8-GPE-treated (□); miGPE-low (n = 6), low dose rAAV8-miGPE-treated (∎) G6pc−/− mice; (+/+), wild type mice (n = 24) (▾). Data are mean ± SEM. *P < 0.05, **P < 0.005.